Literature DB >> 20117340

Imaging techniques in inflammatory bowel disease: recent trends, questions and answers.

M Goetz1, M F Neurath.   

Abstract

Imaging techniques have undergone substantial progress in recent years and contribute significantly in the diagnosis of inflammatory bowel diseases in conjunction with patient history, clinical and laboratory examination. Modern cross-sectional imaging modalities such as computed tomography and magnetic resonance imaging allow an evaluation not only of the complete bowel wall of the small intestine, but also of extraluminal structures. They constitute a major diagnostic component in the initial workup, in stricturing or fistulizing disease and in suspected abscess. Transabdominal ultrasonography has been re-appreciated in these settings as an easy- and ready-to-use tool yielding real-time information. Positron emission tomography was found useful to add functional diagnosis of inflammation. Colonoscopy techniques still represent the gold standard for evaluation of inflammatory activity and for cancer surveillance. Here, chromoendoscopy has proven efficacy for enhanced detection of flat intraepithelial neoplasias in ulcerative colitis and has been incorporated into recent surveillance guidelines. Narrow band imaging may provide virtual chromoendoscopy in the future, but confirmatory studies are still on the way. Confocal endomicroscopy allows in vivo microscopy at high resolution and with excellent accuracy in first trials to predict histology of inflammatory and neoplastic lesions. The current data from endoscopic studies should result in an integrated approach to both identify and characterize a suspicious lesion during ongoing endoscopy for reliable, accurate diagnosis and targeted, immediate therapy. Copyright 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20117340     DOI: 10.1016/S0399-8320(09)73152-5

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  7 in total

1.  Confocal laser endomicroscopy and narrow-band imaging-aided endoscopy for in vivo imaging of colitis and colon cancer in mice.

Authors:  Maximilian J Waldner; Stefan Wirtz; Clemens Neufert; Christoph Becker; Markus F Neurath
Journal:  Nat Protoc       Date:  2011-09-01       Impact factor: 13.491

2.  Ultra high magnification endoscopy: Is seeing really believing?

Authors:  Aman V Arya; Brian M Yan
Journal:  World J Gastrointest Endosc       Date:  2012-10-16

Review 3.  Contrast-enhanced Ultrasound for Detection of Crohn's Disease Activity: Systematic Review and Meta-analysis.

Authors:  Zbigniew Serafin; Marcin Białecki; Agnieszka Białecka; Luca Maria Sconfienza; Maria Kłopocka
Journal:  J Crohns Colitis       Date:  2015-10-27       Impact factor: 9.071

4.  Increased wall thickness using ultrasonography is associated with inflammation in an animal model of experimental colitis.

Authors:  Gülen Arslan Lied; Anne Marita Milde; Kim Nylund; Maja Mujic; Tore Grimstad; Trygve Hausken; Odd Helge Gilja
Journal:  Clin Exp Gastroenterol       Date:  2012-10-02

5.  Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case-control study.

Authors:  Monique M Gerrits; Min Chen; Myrte Theeuwes; Herman van Dekken; Marjolein Sikkema; Ewout W Steyerberg; Hester F Lingsma; Peter D Siersema; Bing Xia; Johannes G Kusters; C Janneke van der Woude; Ernst J Kuipers
Journal:  Cell Oncol (Dordr)       Date:  2011-02-17       Impact factor: 6.730

6.  Bowel perfusion measured with dynamic contrast-enhanced ultrasound predicts treatment outcome in patients with Crohn's disease.

Authors:  Fredrik Saevik; Kim Nylund; Trygve Hausken; Svein Ødegaard; Odd H Gilja
Journal:  Inflamm Bowel Dis       Date:  2014-11       Impact factor: 5.325

Review 7.  Small intestine contrast ultrasonography for the detection and assessment of Crohn disease: A meta-analysis.

Authors:  Chenjing Zhu; Xuelei Ma; Luqi Xue; Jing Xu; Qingfang Li; Yun Wang; Jing Zhang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.